TCL Archive Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted July 19, 1991
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb July 14, 1995
TCL Archive Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost March 20, 2009